Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J20J | ISIN: US44934S2068 | Ticker-Symbol: HWT1
NASDAQ
01.11.24
20:38 Uhr
1,815 US-Dollar
-0,045
-2,42 %
1-Jahres-Chart
ICAD INC Chart 1 Jahr
5-Tage-Chart
ICAD INC 5-Tage-Chart

Aktuelle News zur ICAD Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.10.iCAD to Participate in the LD Micro Main Event XVII158Nashua, New Hampshire--(Newsfile Corp. - October 16, 2024) - iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing...
► Artikel lesen
03.10.iCAD, Inc.: iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 20241
11.09.iCAD, Inc.: iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 20241
14.08.BTIG reaffirms Buy rating on iCAD stock as strong Q2 results boost confidence3
29.07.iCAD, Inc.: iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography2
26.06.iCAD, Inc.: iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 20243
04.06.iCAD, Inc.: iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference1
16.05.Earnings call: iCAD reports growth and strategic advancements in Q1 20241
15.05.iCAD GAAP EPS of -$0.05 beats by $0.01, revenue of $4.95M beats by $0.51M1
14.05.iCAD Q1 2024 Earnings Preview1
08.04.iCAD, Inc.: iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting980NASHUA, N.H., April 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today that new data indicates its...
► Artikel lesen
12.03.iCAD, Inc.: iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results398Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear ending cash balance of $21.7M NASHUA, N.H....
► Artikel lesen
28.11.23iCAD, Inc.: iCAD's AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare527Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare's new MyBreastAI Suite*AI applications streamline workflow and support clinicians in delivering more personalized breast...
► Artikel lesen
27.11.23iCAD, Inc.: iCAD's ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease337New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman's one to two-year risk for breast canceriCAD...
► Artikel lesen
13.11.23iCAD, Inc.: iCAD Reports Financial Results for Third Quarter Ended September 30, 2023232NASHUA, N.H., Nov. 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1